\nPro<\/strong>fessor Sarah Lewington<\/b><\/strong> \n(Principal Investigator, UK)<\/strong><\/p>\n
<\/td>\n
Professor <\/span>Sarah Lewington <\/b>co-leads the \u201cLarge-scale observational studies in diverse <\/span>populations\u201d within the MRC\u2019s Population Health Research Unit (PHRU). She is the <\/span>Oxford-based\u00a0 principal investigator for large cohort studies conducted in Russia (200K participants), Cuba (150K\u00a0 participants) and India (500K participants). She has published >100 articles which have >22,000\u00a0 citations (Scopus <\/span>h<\/span><\/i>-index, 43).<\/span><\/p>\n
<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
Co-Investigators University of Oxford\u00a0<\/strong><\/h1>\n
\n\n
\n
\n
<\/p>\n
Associate Professor Naomi Allen<\/b><\/strong><\/p>\n<\/td>\n
\n
Associate Professor Naomi Allen <\/b>is Senior Epidemiologist for UK Biobank, which is currently\u00a0 performing an imaging sub-study of DXA and MRI imaging in 100,000 participants. She also has\u00a0 research interests in the role of adiposity in cancer development. She has published >300 articles\u00a0 that have been cited >19,000 times (Scopus <\/span>h<\/span><\/i>-index, 78) <\/span><\/strong><\/p>\n
<\/td>\n<\/tr>\n<\/tbody>\n
\n
\n
\n
<\/p>\n
Associate Professor <\/strong>Jonathan Emberson<\/b><\/p>\n
<\/td>\n
Associate Professor <\/strong>Jonathan Emberson <\/b>is a senior statistician and epidemiologist and is the UK\u00a0 Principal Investigator of the Mexico City Prospective Study (150K participants). Based at the MRC PHRU in Oxford, his research is focused on studying the causes and prevention of cardiovascular\u00a0\u00a0<\/span><\/p>\n
(and related) diseases. He has published >100 articles which have been cited ~20,000 times\u00a0 (Scopus <\/span>h<\/span><\/i>-index, 43). <\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n\n
\n
\n
<\/p>\n
Dr <\/strong>Ben Lacey<\/b><\/p>\n
<\/td>\n
\n
Dr <\/strong>Ben Lacey <\/b>is an epidemiologist and consultant public health physician. He is Senior Clinical\u00a0 Research Fellow at the Nuffield Department of Population Health, University of Oxford. He works\u00a0 on large-scale cohort studies in several low and middle income countries, focusing particularly on\u00a0 the effect of adiposity on vascular disease risk. He has published 30 articles (Scopus <\/span>h<\/span><\/i>-index, 7).<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n\n
\n
\n
<\/p>\n
Professor Fredrik Karpe<\/strong><\/p>\n
<\/td>\n
\n
Professor Fredrik Karpe<\/strong> is head of OCDEM and founded the Oxford Biobank which has a large\u00a0 DXA-based cohort (n=5,500). His research has been in human metabolism in relation to obesity,\u00a0 type 2 diabetes and cardiovascular disease. He has published >200 articles which have >26,000\u00a0 citations (Scopus <\/span>h<\/span><\/i>-index, 73). <\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
<\/p>\n
Co-Investigators (Malaysia)<\/strong><\/h1>\n
\n\n
\n
<\/p>\n
Associate Professor Dr. Nor Azian Murad<\/strong><\/p>\n
<\/td>\n
\n
Associate Professor Dr. Nor Azian Murad<\/strong> <\/b>is a Research Fellow at 集美麻豆 Medical Molecular Biology Institute\u00a0 (UMBI). Her research interest is in non-communicable diseases focusing on genetic predisposition\u00a0 as well as gene-environment interaction. She has published 25 articles (Scopus <\/span>h<\/span><\/i>-index, 5).<\/span><\/p>\n